Mitsubishi Chemical Group. Science. Value. Life.
Explore Our Treatments

One Scientific Breakthrough Can Change Countless Lives

In pursuit of the impossible

Watch Now

We believe in helping people who are struggling with serious and debilitating diseases.

Learn More About Us
SCIENCE
Delivering On
Unmet Needs

Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses.

Learn About Our Work
AMYOTROPHIC LATERAL SCLEROSIS
Our Relentless Commitment

Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs.

Learn more about ALS
News

Important news about our latest developments in science & medicine.

See All
Dec 05, 2023
Mitsubishi Tanabe Pharma America Announces Presentations in ALS at 34th International Symposium on ALS/MND Read More
Oct 16, 2023
Mitsubishi Tanabe Pharma America Spotlights ALS Research at the XXVI World Congress of Neurology Read More
Oct 04, 2023
Mitsubishi Tanabe Pharma America Showcases Depth of ALS Research with Wide Range of Abstracts at 22nd Annual NEALS Meeting Read More
Aug 29, 2023
Mitsubishi Tanabe Pharma America Presents Positive Results from Pivotal Phase 3 BouNDless Trial of Investigational ND0612 in People with Parkinson's Disease Experiencing Motor Fluctuations Read More
Aug 28, 2023
Mitsubishi Tanabe Pharma America Announces Presentations in Parkinson’s Disease at 2023 International Congress of Parkinson's Disease and Movement Disorders Society (MDS) Read More
Aug 17, 2023
Mitsubishi Tanabe Pharma America Announces Post-Hoc Analysis Examining Effect of Early Intervention with RADICAVA® (edaravone) on Survival and Disease Progression Milestones in People with ALS Read More
You are leaving this website, hosted by Mitsubishi Tanabe Pharma America, Inc.
This link will take you to a website to which our Privacy Policy and Terms of Use does not apply. Mitsubishi Tanabe Pharma America, Inc. does not control the content of this third-party site.
Continue
Cancel